CYB5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.53190024501748E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.4270000149923E-09 |
Normal-vs-Stage2 |
3.501700041042E-09 |
Normal-vs-Stage3 |
1.51949564042297E-11 |
Normal-vs-Stage4 |
5.38330491295369E-11 |
Stage1-vs-Stage2 |
1.922570E-01 |
Stage1-vs-Stage3 |
1.601960E-03 |
Stage1-vs-Stage4 |
1.212180E-02 |
Stage2-vs-Stage3 |
3.411800E-01 |
Stage2-vs-Stage4 |
4.782000E-01 |
Stage3-vs-Stage4 |
8.141600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.79130052405208E-10 |
Normal-vs-AfricanAmerican |
1.32880000336399E-08 |
Normal-vs-Asian |
8.514200E-02 |
Caucasian-vs-AfricanAmerican |
7.464800E-01 |
Caucasian-vs-Asian |
4.929400E-01 |
AfricanAmerican-vs-Asian |
3.533000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.1720002746074E-10 |
Normal-vs-Female |
2.64720001474927E-09 |
Male-vs-Female |
1.469850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.117010E-03 |
Normal-vs-Age(41-60Yrs) |
5.72640002083347E-09 |
Normal-vs-Age(61-80Yrs) |
1.76589853850828E-11 |
Normal-vs-Age(81-100Yrs) |
2.20829999841854E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.076200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.801000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.861600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.339200E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.923400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.588200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.960000E-03 |
Normal-vs-Grade 2 |
1.34330002676819E-09 |
Normal-vs-Grade 3 |
4.5878001397881E-10 |
Normal-vs-Grade 4 |
1.97630800613524E-12 |
Grade 1-vs-Grade 2 |
1.455780E-01 |
Grade 1-vs-Grade 3 |
1.338020E-01 |
Grade 1-vs-Grade 4 |
6.484300E-03 |
Grade 2-vs-Grade 3 |
4.857600E-01 |
Grade 2-vs-Grade 4 |
2.100000E-03 |
Grade 3-vs-Grade 4 |
2.431800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.19020002134585E-09 |
Normal-vs-ccB subtype |
8.63520033256293E-10 |
ccA subtype-vs-ccB subtype |
3.849800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.04949995547588E-10 |
Normal-vs-N1 |
7.119500E-03 |
N0-vs-N1 |
5.184600E-01 |
|
|